Junting Zheng, MS

Research Biostatistician II

Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Departmental Newsletter
Career Opportunities
Quantitative Sciences Undergraduate Research Experience (QSURE)
Software

Junting Zheng, MS

Research Biostatistician II

Share
Print
Share
Print
Junting Zheng, MS

Office Phone

646-888-8287

Email

zhengj@mskcc.org

Education

University of Iowa

Current Research Interests

Ms. Zheng primarily collaborates with researchers in bone marrow transplant (BMT) and radiology. She works with Dr. Heller on a variety of projects including 1) exploring the effect of KIR ligands and HLA genotypes for patients with neuroblastoma, and 2) using joint model to analyze longitudinally measured markers for immune recovery and survival outcomes for the patients undergone BMT. She also works with Dr. Moskowitz on radiology service to access measurement of accuracy and to evaluate detection improvement with recent advanced techniques in MRI and CT scans, mainly for patients with prostate cancer and patients with renal cortical tumors.

Ms. Zheng also collaborates on basic science research studies and many other clinical projects including lung cancer, gastrointestinal cancer, and lymphoma. Her Research interests include longitudinal survival joint model, mixed effects model, estimating ROC curve as well as evaluating covariates effect on the measurement of accuracy.

Publications

Selected Bibliography

  1. Akin O, Gultekin D, Vargas HA, Zheng J, Moskowitz CS, Pei X, Sperling D, Schwartz L, Hricak H, Zelefsky M. Incremental Value of Diffusion Weighted and Dynamic Contrast Enhanced MRI in the Detection of Locally Recurrent Prostate Cancer after Radiation Treatment: Preliminary Results. Eur Radiol. 2011 May 1. [Epub ahead of print]
  2. Ponce DM, Zheng J, Gonzales A, Lubin M, Heller G, Castro-Malaspina H, Giralt S, Hsu KC, Jakubowski AA, Jenq RR, Koehne G, Papadopoulos EB, Perales MA, van den Brink MR, Young JW, Boulad F, Kernan NA, Kobos R, Prockop S, Scaradavou A, Small T, O'Reilly RJ, and Barker JN. Reduced Late Mortality Risk Contributes to Similar Survival after Double Unit Cord Blood Transplantation as Compared with Related and Unrelated Donor Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2011 Jan 11. [Epub ahead of print]
  3. Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, Dematteo RP, Strong VE. Laparoscopic Versus Open Gastric Resections for Primary Gastrointestinal Stromal Tumors (GISTs): A Size-Matched Comparison. Ann Surg Oncol. 2011 Jan 5. [Epub ahead of print]
  4. Vargas HA, Akin O, Zheng J, Moskowitz CS, Soslow R, Abu-Rustum N, Barakat RR, Hricak H. The Value of MR Imaging When the Site of Uterine Cancer Origin Is Uncertain. Radiology. 2011 Mar; 258 (3):785-92.
  5. Venstrom JM, Zheng J, Noor N, Danis KE, Yeh AW, Cheung IY, Dupont B, O'Reilly RJ, Cheung NK, Hsu KC. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. Clin Cancer Res. 2009 Dec 1; 15 (23):7330-4.